Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial board
OmniDoctor
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Home
>
Search
>
Author Details
Author Details
Феденко, Александр Александрович
Issue
Section
Title
File
Vol 19, No 3 (2017)
Articles
The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation
(Rus)
Vol 22, No 4 (2020)
CLINICAL ONCOLOGY
Differentiated thyroid cancer
(Rus)
Vol 23, No 2 (2021)
CLINICAL ONCOLOGY
Prostate cancer
(Rus)
Vol 23, No 3 (2021)
CLINICAL ONCOLOGY
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
(Rus)
Vol 23, No 4 (2021)
CLINICAL ONCOLOGY
Gastric cancer: Russian clinical guidelines
(Rus)
Vol 24, No 2 (2022)
CLINICAL ONCOLOGY
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report
(Rus)
Vol 24, No 3 (2022)
CLINICAL ONCOLOGY
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
(Rus)
Vol 24, No 4 (2022)
CLINICAL ONCOLOGY
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study
(Rus)
Vol 26, No 1 (2024)
Articles
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia
(Rus)
Vol 26, No 2 (2024)
Articles
Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP